Search

everythinglearnresearchcommunity

for

Search:↓

Men, especially older ones with health issues like prostate cancer, may have worse COVID-19 outcomes and could benefit from therapies targeting male hormones.

Large prostate links to more hair loss, but age of onset doesn't affect it.

The ABI1 gene contributes to prostate cancer progression and treatment resistance.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

Taking finasteride for benign prostate hyperplasia may increase the risk of osteoporosis, especially at higher doses.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Dutasteride and finasteride have similar effects on prostate cancer risk in BPH patients.

Zapoteca portoricensis extract may help protect against prostate issues and support liver and kidney health in rats.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

More prostate biopsies increase the chance of finding cancers that may not need treatment.

Researchers found an RNA transcript that might help control a growth factor linked to tumor development.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

Doxil showed some effectiveness against advanced prostate cancer but caused severe side effects at higher doses.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

African American men with prostate cancer have more androgen receptor mutations, which may lead to more aggressive cancer compared to Caucasian American men.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Certain genetic variants increase the risk of resistance to hormone therapy in prostate cancer patients.

Dutasteride may help shrink prostate cancer tumors.

Artocarpus heterophyllus seed extract may help treat prostate inflammation without side effects.

Kolaviron and quercetin may help treat prostate issues.

Physical activity, height, and smoking affect prostate cancer risk.

New treatments are making advanced prostate cancer management more complex but also more hopeful.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

Finasteride reduces bleeding during prostate surgery.